Upcoming Meetings and Updates
Haemapheresis Conference in the Netherlands
NL. The Hague,21.-22. November 2024Novel Boundaries in Haemapheresis and Cell Therapy
Link for Regisrtation:
https://www.haemapheresisconference.nl/
REMINDER: Deadline for Abstract submission:
3. November 2024
PREVIOUS Important
CAR-T Webinar Wednesday, February 22, 2023, 3 pm to 4:30 pm (GMT+1)
The European Society for Hemapheresis is happy to host, in collaboration with
Terumo Blood and Cell technologies, an update on CAR-T with two experts from the Hospital Clínic of Barcelona in Spain
Dr. Miquel Lozano Mononuclear cell collection for CAR-T therapies
,Dr. Julio Delgado Novel applications of CAR-T therapies
UPDATE from the 22nd ESFH CONGRESS
held as a hybrid joint meeting of the
Turkish Hematology Society, WAA and ESFH
September 14th – 17th, 2022, Istanbul, Turkey
AWARDS:Abstract Award (Certificate 500€)Dr.SerraAltuntasTitle: Is there any predictive laboratory parameter to predict the success of hemoadsorption in Sepsis Co-Authors: Altuntas S, Yigenoglu TN, Basci S, Durmusoglu E, Silgeciler H, Kilinc A, Altuntas F., Yüksek Ihtisas University, Faculty of Medicine. Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital.Helmut Borberg AwardDr. Bernd StegmayrSenior Prof. of UMEA University, Sweden, Department of Public Health and Clinical MedicineTitle of the lecture: My reflections of the therapeutic power and risks of various apheresis approaches”Update
PROGRAM and Content for downloadof the
21st Congress 2021, May 26th - 27th Digital
Presentations and Session VideosH. Vrielink Convalescent Plasma: from whom and when (pdf)
Video Hans Vrielink MD PhD: Convalescent plasma: from whom and when
M.Lozano Apheresis techniques in the treatment of severe COVID-19 patients (pdf)
Video:Miquel Lozano: Apheresis techniques in the treatment of severe COVID-19 patients
L.Pierelli Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic (pdf)
Video Luca Pierell: Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic
M.-J Mustieles: Vascular Aaccess: Always Central Line? (pdf)
Video M.J. Mustieles:Vascular Aaccess: Always Central Line?
Video Marie Scully:New treatment strategies in management of TTPPresentations and Session Videos
H. Vrielink Convalescent Plasma: from whom and when (pdf)
Video Hans Vrielink MD PhD: Convalescent plasma: from whom and when
M.Lozano Apheresis techniques in the treatment of severe COVID-19 patients (pdf)
Video:Miquel Lozano: Apheresis techniques in the treatment of severe COVID-19 patients
L.Pierelli Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic (pdf)
Video Luca Pierell: Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic
M.-J Mustieles: Vascular Aaccess: Always Central Line? (pdf)
Video M.J. Mustieles:Vascular Aaccess: Always Central Line?Webinars produced by Terumo BCT with the collaboration of ESFH
Previous WAA WEBINAR September 15, 2021, 12:00 pm -2:00pm (EST)
Role of Apheresis in Cellular Therapies and Thrombosis Following COVID- 19
https://us02web.zoom.us/webinar/register/WN_61FziquaSTGXv7uj0R1DiQWebinar “How to optimize blood transfusion treatment outcomes for SCD patients?”
On-Demand Webinar One Year In: Lessons Learned About Transfusion of Convalescent Plasma (CP) for COVID-19
Presented by
Dr. Miquel Lozano, Chief, Hemotherapy Section, Hospital Clinic de Barcelona, Spain
Dr. Claudia Cohn, Chief Medical Officer, AABB
Dr. Leandro Burgos Pratx, Executive Chief of the Service of Transfusion Medicine, Hospital Italiano of Buenos Aires, Brazil
Dr. Silvano Wendel, Medical Director, Hospital Sirio Libanes São Paulo, Brazil
Deirdre Fehily, PhD, Policy Officer – Substances of Human Origin Team, European Commission